During 2024 the group inoculated a record number of volunteers
hVivo (HVO:AIM) 10.53p Loss to date: 62.6% We highlighted CRO (contract research organisation) hVivo (HVO:AIM) in September 2024 for its leading position in the fast growing HCT (human challenge trials) market. Industry experts forecast the market will grow from its current size of between $100 million and $150 million a year to between $700 million and $1 billion, and hVIVO itself plans to grow revenue to £100 million by...